The British Medical Association calls for ban on puberty blockers to be lifted

The British Medical Association (BMA) has advocated for the removal of the ban on puberty blockers for individuals under 18. The medical association also requests a halt in the implementation of a significant review regarding gender care for young people. The BMA expressed the need to assess the Cass Review after academics raised concerns about its methodology.

The review, initiated by NHS England, recommends shifting away from medical treatments for children grappling with their gender identity, favouring a more comprehensive approach with enhanced mental health support. Conducted over four years, the review has received widespread approval from the UK's medical community. Led by esteemed paediatrician Dr. Hilary Cass, the review prompted the previous government to prohibit the use of puberty blockers for under-18s questioning their gender. Labour upheld this decision upon their electoral victory.

Image Credit: Canva

These medications inhibit the natural production of hormones, thus delaying puberty onset. The prohibition applied to private clinics since the NHS had already ceased their use outside clinical trials. This ban was contested in the High Court by the advocacy group TransActual, but a judge ruled earlier this week that the ban is lawful.

As ‘BBC’ reports, the BMA disclosed that its Council, the main decision-making body, had voted in favour of a motion last month that criticised the Cass Review and called for the union to “publicly critique” it. The BMA voiced concerns over the impact on transgender healthcare due to “unsubstantiated recommendations.” It referenced research published online earlier this year, indicating academic apprehensions regarding the Cass Review's conduct. Prof Philip Banfield, a BMA leader, emphasised the importance of ensuring appropriate care and support in this specialised healthcare area.

The BMA aims to complete its evaluation by the year’s end and seeks to pause the Cass Review's implementation in the interim. Meanwhile, a spokesperson for the Cass Review defended its process, highlighting that the University of York conducted the most extensive and thorough evidence review on the subject, examining 237 papers from 18 countries. The review also incorporated extensive consultations with those having lived experiences, healthcare staff, and leading experts in the field.

A Department of Health and Social Care spokesperson stated: “The Cass Review is a robust report backed by clinicians and firmly grounded in evidence. NHS England will be implementing Dr. Cass's recommendations so that children and young people receive the safe, comprehensive care and support they need. We do not support a delay to necessary improvements in NHS gender services.”

Read related myGwork articles here:

Puberty blockers ban ruled lawful by high court

Labour moves to ban puberty blockers in a blow to trans rights

Scotland pauses prescriptions of puberty blockers for trans minors

England’s health service to stop prescribing puberty blockers to trans kids

Keep up to date with the latest myGnews

LGBTQ+ professionals, LGBTQ+ Graduates, LGBTQ+ professional network, LGBTQ+ professional events, LGBTQ+ networking events, LGBTQ+ Recruitment, LGBTQ+ Friendly organizations, LGBTQ+ Friendly companies, LGBTQ+ jobs